Doreen E. Cashen
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Regulation of Appetite and Obesity, Biochemical Analysis and Sensing Techniques, Sexual function and dysfunction studies, Neuroendocrine Tumor Research Advances, melanin and skin pigmentation
Most-Cited Works
- → A role for the melanocortin 4 receptor in sexual function(2002)299 cited
- → Design and Pharmacology of N-[(3R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor Agonist(2002)190 cited
- → Acidic Fibroblast Growth Factor Accelerates Dermal Wound Healing in Diabetic Mice(1995)89 cited
- → Activation of melanocortin MC4 receptors increases erectile activity in rats ex copula(2002)82 cited
- → Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase(2002)60 cited
- → Acidic Fibroblast Growth Factor Accelerates Dermal Wound Healing(1992)54 cited
- → Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-2-methyl-2-azabicyclo[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4 receptor agonist(2005)37 cited
- → Antidiabetic Activity of a Highly Potent and Selective Nonpeptide Somatostatin Receptor Subtype-2 Agonist(2006)25 cited
- → Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist(2010)23 cited
- → Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist(2011)16 cited